TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

Dr. Reddy's

OncologyCardiovascularInfectious Disease
Generics

Dr. Reddy's is a generic drug manufacturer focused on Oncology, Cardiovascular, Infectious Disease. Key products include CYCLOPHOSPHAMIDE.

1974
Since
310
Drugs
-
Trials
2776
Approved (2yr)

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 34%
24 drugs Phase 3: 1
Cardiovascular 22%
16 drugs
Infectious Disease 17%
12 drugs
Respiratory 15%
11 drugs
Gastroenterology 12%
9 drugs

Pipeline Strength Pro

Loading...